|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.889 USD | +0.73% |
|
+4.20% | +18.86% |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 131.27USD | +4.21% | +6.95% | 9.34% | |
| 528.04USD | +6.03% | +16.47% | 9.05% | |
| 374.15USD | +3.55% | +14.31% | 8.97% | |
| 654.27USD | +4.73% | -15.24% | 5.98% | |
| 312.78USD | +3.68% | -21.34% | 3.29% | |
| 111.60USD | +4.30% | -35.88% | 2.4% | |
| 216.12USD | +3.04% | +22.80% | 2.07% | |
| 555.91USD | +1.60% | +14.09% | 1.63% | |
| 79.76USD | +10.01% | +170.46% | 1.52% | |
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | US$9.889 | +0.73% | 67,847 |
| 26-07-02 | US$9.817 | +2.31% | 203,156 |
| 26-07-01 | US$9.595 | -0.07% | 127,922 |
| 26-06-30 | US$9.602 | +1.44% | 2,503 |
| 26-06-29 | US$9.466 | -0.25% | 52,605 |
Other stock markets
Delayed Quote Swiss Exchange
Last update July 03, 2026 at 11:36 am
Description
| IE00BYXG2H39 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | Stocks |
| Sector | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
| Autres ETFs | |
Features and characteristics
| Dividend Policy | Capitalisation |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Date of creation |
2017-10-18
|
| Geographical Focus |
AuM evolution - 2026-02-26
| AuM (USD) | 936M |
|---|---|
| AuM 1M | 890M |
| AuM 3 months | 823M |
| AuM 6 months | 559M |
| AuM 12 months | 562M |
- Stock Market
- ETF
- BTEC ETF
Select your edition
All financial news and data tailored to specific country editions
